Cargando…
Use of Biologic Agents in Ocular Manifestations of Rheumatic Disease
Biologic agents have dramatically shifted the treatment paradigm for rheumatic disease. Use of these agents can decrease disease burden, allow the patient to be weaned from corticosteroids, and reduce the likelihood of relapse. Eye disease associated with rheumatic conditions may present with a wide...
Autores principales: | Kraus, Courtney L., Culican, Susan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3246731/ https://www.ncbi.nlm.nih.gov/pubmed/22229035 http://dx.doi.org/10.1155/2012/203819 |
Ejemplares similares
-
New advances in amblyopia therapy II: refractive therapies
por: Kraus, Courtney L, et al.
Publicado: (2018) -
New advances in amblyopia therapy I: binocular therapies and pharmacologic augmentation
por: Kraus, Courtney L, et al.
Publicado: (2018) -
Challenging presentations of cavernous sinus thrombophlebitis
por: Kraus, Courtney L., et al.
Publicado: (2011) -
Nummular keratopathy in a patient with Hyper-IgD Syndrome
por: Kraus, Courtney L, et al.
Publicado: (2009) -
Ocular involvement in rheumatic diseases
por: Dankiewicz-Fares, Iwona, et al.
Publicado: (2023)